Taichi Matsubara

1.7k total citations
79 papers, 1.3k citations indexed

About

Taichi Matsubara is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Taichi Matsubara has authored 79 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 50 papers in Oncology and 15 papers in Surgery. Recurrent topics in Taichi Matsubara's work include Lung Cancer Treatments and Mutations (29 papers), Cancer Immunotherapy and Biomarkers (26 papers) and Lung Cancer Diagnosis and Treatment (24 papers). Taichi Matsubara is often cited by papers focused on Lung Cancer Treatments and Mutations (29 papers), Cancer Immunotherapy and Biomarkers (26 papers) and Lung Cancer Diagnosis and Treatment (24 papers). Taichi Matsubara collaborates with scholars based in Japan. Taichi Matsubara's co-authors include Shinkichi Takamori, Naoki Haratake, Gouji Toyokawa, Yoshihiko Maehara, Takaki Akamine, Yuka Kozuma, Tatsuro Okamoto, Kazuki Takada, Yoshinao Oda and Fumihiro Shoji and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Taichi Matsubara

75 papers receiving 1.3k citations

Peers

Taichi Matsubara
Taichi Matsubara
Citations per year, relative to Taichi Matsubara Taichi Matsubara (= 1×) peers Masakazu Katsura

Countries citing papers authored by Taichi Matsubara

Since Specialization
Citations

This map shows the geographic impact of Taichi Matsubara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taichi Matsubara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taichi Matsubara more than expected).

Fields of papers citing papers by Taichi Matsubara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taichi Matsubara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taichi Matsubara. The network helps show where Taichi Matsubara may publish in the future.

Co-authorship network of co-authors of Taichi Matsubara

This figure shows the co-authorship network connecting the top 25 collaborators of Taichi Matsubara. A scholar is included among the top collaborators of Taichi Matsubara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taichi Matsubara. Taichi Matsubara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsubara, Taichi, Fumihiko Kinoshita, Takaki Akamine, et al.. (2024). Clinical and Prognostic Significance of Glutathione Peroxidase 2 in Lung Adenocarcinoma. Annals of Surgical Oncology. 31(7). 4822–4829. 7 indexed citations
2.
Akamine, Takaki, Taichi Matsubara, Masafumi Yamaguchi, et al.. (2024). Is Sublobar Resection Feasible for High-Risk Pathologic Stage I Non-small Cell Lung Cancer?. Annals of Surgical Oncology. 32(6). 4161–4172. 1 indexed citations
3.
Kinoshita, Fumihiko, Tetsuzo Tagawa, Tomoyoshi Takenaka, et al.. (2021). Prognostic value of postoperative decrease in serum albumin on surgically resected early-stage non-small cell lung carcinoma: A multicenter retrospective study. PLoS ONE. 16(9). e0256894–e0256894. 9 indexed citations
4.
Matsubara, Taichi, Shinkichi Takamori, Takatoshi Fujishita, et al.. (2021). Successful treatment of locally advanced lung cancer using late concurrent chemoradiation therapy administered after immune checkpoint inhibitor plus platinum chemotherapy. Thoracic Cancer. 12(23). 3286–3289. 1 indexed citations
5.
Matsubara, Taichi, Takashi Seto, Shinkichi Takamori, et al.. (2021). Anti–PD-1 Monotherapy for Advanced NSCLC Patients with Older Age or Those with Poor Performance Status. OncoTargets and Therapy. Volume 14. 1961–1968. 12 indexed citations
6.
Takada, Kazuki, Shinkichi Takamori, Taichi Matsubara, et al.. (2020). Clinical significance of preoperative inflammatory markers in non-small cell lung cancer patients: A multicenter retrospective study. PLoS ONE. 15(11). e0241580–e0241580. 12 indexed citations
7.
Matsubara, Taichi, Gouji Toyokawa, Kazuki Takada, et al.. (2019). The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial–mesenchymal transition in resected lung adenocarcinoma. PLoS ONE. 14(5). e0215103–e0215103. 9 indexed citations
8.
Matsubara, Taichi, Hiroshi Uchi, Naoki Haratake, et al.. (2019). Acute Generalized Exanthematous Pustulosis Caused by the Combination of Pembrolizumab Plus Chemotherapy in a Patient With Squamous-Cell Carcinoma. Clinical Lung Cancer. 21(2). e54–e56. 16 indexed citations
9.
Matsubara, Taichi, Kazuki Takada, & Yoshihiko Maehara. (2019). ASO Author Reflections: PD-L2 Expression in Lung Squamous Cell Carcinoma—One of the Potential Important Prognostic Factors. Annals of Surgical Oncology. 26(S3). 676–677. 2 indexed citations
10.
Matsubara, Taichi, Tetsuzo Tagawa, Kazuki Takada, et al.. (2019). Clinical and Prognostic Significance of the Epithelial–Mesenchymal Transition in Stage IA Lung Adenocarcinoma: A Propensity Score–Matched Analysis. Clinical Lung Cancer. 20(4). e504–e513. 10 indexed citations
11.
Takamori, Shinkichi, Gouji Toyokawa, Mototsugu Shimokawa, et al.. (2018). The C-Reactive Protein/Albumin Ratio is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma: A Retrospective Multi-institutional Study. Annals of Surgical Oncology. 25(6). 1555–1563. 17 indexed citations
12.
Takamori, Shinkichi, Tetsuzo Tagawa, Gouji Toyokawa, et al.. (2018). The significant influence of having children on the postoperative prognosis of patients with nonsmall cell lung cancer: A propensity score‐matched analysis. Cancer Medicine. 7(7). 2860–2867. 1 indexed citations
13.
Takamori, Shinkichi, Gouji Toyokawa, Tatsuro Okamoto, et al.. (2018). Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer. Annals of Surgical Oncology. 25(5). 1229–1236. 44 indexed citations
14.
Takamori, Shinkichi, Gouji Toyokawa, Hiroaki Ueo, et al.. (2017). Family-associated factors influence the postoperative prognosis in patients with non-small cell lung cancer. Annals of Oncology. 28. v509–v509. 2 indexed citations
15.
Shoji, Fumihiro, Taichi Matsubara, Yuka Kozuma, et al.. (2017). Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer. Anticancer Research. 37(12). 6997–7003. 38 indexed citations
16.
Matsubara, Taichi, Gouji Toyokawa, Yuichi Yamada, et al.. (2017). A Case of the Resected Lymphohistiocytoid Mesothelioma: BAP1 Is a Key of Accurate Diagnosis. Anticancer Research. 37(12). 6937–6941. 2 indexed citations
17.
Toyokawa, Gouji, Yuka Kozuma, Taichi Matsubara, et al.. (2017). Prognostic impact of controlling nutritional status score in resected lung squamous cell carcinoma. Journal of Thoracic Disease. 9(9). 2942–2951. 63 indexed citations
18.
Toyokawa, Gouji, Mototsugu Shimokawa, Yuka Kozuma, et al.. (2017). Invasive features of small-sized lung adenocarcinoma adjoining emphysematous bullae. European Journal of Cardio-Thoracic Surgery. 53(2). 372–378. 10 indexed citations
19.
Toyokawa, Gouji, Kazuki Takada, Tatsuro Okamoto, et al.. (2017). Elevated Metabolic Activity on 18F-FDG PET/CT Is Associated with the Expression of EZH2 in Non-small Cell Lung Cancer. Anticancer Research. 37(3). 1393–1402. 7 indexed citations
20.
Mima, Akira, Akihiro Kanematsu, Taichi Matsubara, et al.. (2008). Induction of continuous ambulatory peritoneal dialysis after retroperitoneoscopic nephrectomy. Clinical Nephrology. 70(12). 558–560. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026